 The above list of factors is not exhaustive.  We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise. The non-GAAP financial measures include: adjusted EPS, earnings before interest, tax, depreciation and amortization (EBITDA), adjusted EBITDA, net debt, Specialty platform operating income, Specialty platform gross margin percentage, adjusted operating income, return on invested capital, net debt/ EBITDA, and the exclusion of corporate charges in certain calculations. S&P 500 All time high of $43.34 July 1st, 2014 PolyOne Corporation Page 9 2006 2014 2015 Target “Where we were” “Where we are” (Est. in 2012) 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 14.7% 12 – 16% Global Specialty Engineered Materials 1.1% 12.1% 12 – 16% Designed Structures & Solutions 1.4% (2012) 7.3% 8 – 10% Performance Products & Solutions 5.5% 7.7% 9 – 12% Distribution 2.6% 6.1% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 65% 65 – 75% 3) ROIC* 5.0% 11.3% 15% 4) Adjusted EPS Growth N/A 37% Double Digit Expansion *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Proof of Performance & 2015 Goals PolyOne Corporation Page 10 Continuing Earnings Growth Double Digit EPS Expansion Ongoing LSS Programs Incremental Share Buybacks Mergers & Acquisitions Continued Gross Margin Expansion Mid Single Digit Revenue Growth Accelerated Innovation & Mix Improvement PolyOne Corporation Page 11 Innovation Drives Earnings Growth *Percentage of Specialty Platform revenue from products introduced in last five years $20 $53 2006 2014 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* 14% 27% 2006 2014 Specialty Platform Gross Margin % 20% 44% 2006 2014 Specialty Vitality Index Target ≥ 35% PolyOne Corporation Page 12 Megatrends Aligned with Key End Markets Decreasing Dependence on Fossil Fuels Protecting the Environment Improving Health and Wellness Megatrend End Markets Globalizing and Localizing Health & Wellness Transportation Packaging Consumer PolyOne Corporation Page 13 60% 94% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2014 Pension Funding** As of December 31, 2014 Debt Maturities & Pension Funding – 12/31/14 Net Debt / EBITDA* = 1.9x $49 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of December 31, 2014 ($ millions) Coupon Rate: 7.500% 7.375% 5.250% ** includes US-qualified pension plans only *TTM 12/31/2014 PolyOne Corporation Page 14 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return  Expanding our sales, marketing, and technical capabilities  Investing in operational and LSS initiatives (including synergy capture)  ~75% of capital expenditures fund growth initiatives Organic Growth Acquisitions Share Repurchases Dividends $0.16 $0.20 $0.24 $0.32 $0.40 $0.10 $0.20 $0.30 $0.40 $0.50 2011 2012 2013 2014 2015 Annual Dividend  Targets that expand our: • Specialty offerings • End market presence • Geographic breadth • Operating Margin  Synergy opportunities  Adjacent material solutions  Repurchased 1.6 million shares in Q4 2014  Repurchased 11.3 million shares since early 2013  8.7 million shares are available for repurchase under the current authorization PolyOne Corporation Page 15 PolyOne Core Values Innovation Collaboration Excellence PolyOne Corporation Page 16 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne?

intends to use the net proceeds from the offering to finance, in part, its pending acquisitions of Clariant AG's global masterbatch business (the "Clariant masterbatch acquisition") and Clariant Chemicals (India) Limited's masterbatch business (collectively, the "acquisitions"). will redeem all outstanding notes at the "special mandatory redemption price" equal to 100% of the principal amount of the notes plus accrued and unpaid interest, if any, to, but not including, the special mandatory redemption date. The above list of factors is not exhaustive.

intends to use the net proceeds from the offering to finance, in part, its pending acquisitions of Clariant AG's global masterbatch business (the "Clariant masterbatch acquisition") and Clariant Chemicals (India) Limited's masterbatch business (collectively, the "acquisitions"). will redeem all outstanding notes at the "special mandatory redemption price" equal to 100% of the principal amount of the notes plus accrued and unpaid interest, if any, to, but not including, the special mandatory redemption date.    The above list of factors is not exhaustive.

Table 2 lists the properties of common tool steels and the typical mold components for which they are used. A 3°–5° draft per side on all long draw areas is recommended. Startup problems occur during the launch of a new tool or machine.

Applicable to multiple products; injection molding parameters, startup and shutdown, mold design, and troubleshooting recommendations for Edgetek™ High Performance Formulations

Cesa™ Clean Additives WHEN TO USE CESA CLEAN As a best practice, Cesa Clean adds value when used for: • Color changeovers • Material and formulation changes • Shutdown or startup • Machine maintenance WHY USE CESA CLEAN Some of the ways you can benefit from consistently using Cesa Clean: • Improve production uptime with faster color changeovers • Reduce wasted melt puddle material • Reduce resin use during purging • Non-abrasive and safe to use on precision equipment PRODUCT BULLETIN Cesa Clean solutions are available for use in a variety of processing conditions and operating temperatures. DESCRIPTION CHARACTERISTICS PROCESSES CC10120195WE Multi-purpose purge concentrate that is miscible with all resin systems Performance up to 280°C Extrusion, molding, injection and film processes 1.844.4AVIENT www.avient.com Copyright © 2023, Avient Corporation. You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product.

High-quality injection molded parts require extensive knowledge of the molding process, excellent trouble-shooting skills, careful attention to startup parameters, and consistent management of the process throughout the entire production run.

NYSE: POL), a leading global provider of specialized polymer materials, services and solutions, today held its 2017 annual meeting of shareholders, during which time all presented proposals before shareholders were approved. success, and we wish her all the best," said To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/polyone-shareholders-approve-all-proposals-at-2017-annual-meeting-300456487.html

Homepage // News Center // From Inspiration to Innovation: PolyOne Launches All New Website EDITORS: For a high-resolution image, please click here: All New PolyOne.com

The above list of factors is not exhaustive. The non-GAAP financial measures include: adjusted EPS, adjusted operating income, free cash flow and adjusted EBITDA. Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA Median: 81% Median: 78% HIGH FREE CASH FLOW CONVERSION Avient reflects 2021 estimated EBITDA of $580M and excludes one-time synergy capture CAPEX ($20M) Source: Peer data per Bloomberg market data as of July 28, 2021 87 90 86 82 80 78 73 87 82 82 79 79 78 78 77 76 71 67 46 A vi en t K W R P P G A V Y F U L R P M G C P F M C U N V R C E IF F A S H E C L B N R E M N H X L H U N K R A S C L A L B (6) Source: Peer data per Bloomberg market data as of July 28, 2021 Total Enterprise Value / 2021E EBITDA Our current valuation with updated guidance implies an EBITDA multiple that is below specialty formulator peers and the median of other selected chemical / specialty companies.